FDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency

Octapharma USA, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new 2-gram presentation ...
Business Wire

Lyophilized Drugs, Reconstitution Devices and Injection Market Report 2024 - The Importance of Technology and Regulatory Factors on Commercialization and Market Access ...

DUBLIN--(BUSINESS WIRE)--The "Lyophilized Drugs, Reconstitution Devices and Injection Markets: Products, Markets, Therapeutics, Strategies & Forecasts" report has been added to ...
Healio

FDA grants orphan drug designation to porosome reconstitution therapy for cystic fibrosis

Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to porosome reconstitution therapy for treating patients with cystic ...
WDAF-TV

Progressive Medical, Inc. Awarded Drug Reconstitution and Transfer Devices Agreement with Premier, Inc.

PMI is pleased to announce that it has been awarded a group purchasing agreement for the Drug Reconstitution and Transfer Devices category with Premier, Inc. FENTON ...
Reuters

Becton Dickinson defeats Baxter patent lawsuit over drug-transfer system

U.S. judge finds BD's devices do not violate Baxter's drug reconstitution patents BD still facing separate Baxter patent case over medical-infusion pumps (Reuters) - Becton, Dickinson & Co convinced a ...
Becker's Hospital Review

Challenged by effectively managing drug supply and drug waste: How Providence Hospital improved drug administration

Enter Providence Hospital. The 349-bed facility in Mobile, Ala., cares for more than 15,000 inpatients and 150,000 outpatients each year, and improving workflow was a daily challenge for hospital ...